<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03499574</url>
  </required_header>
  <id_info>
    <org_study_id>17028</org_study_id>
    <nct_id>NCT03499574</nct_id>
  </id_info>
  <brief_title>Feasibility Study of Biofeedback in Dysphagia Therapy Post Stroke</brief_title>
  <official_title>A Randomised Controlled Feasibility Trial of Dysphagia Therapy Using Biofeedback in Patients With Acute Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Health Research, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nottingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the feasibility of delivering swallowing therapy using surface&#xD;
      electromyography as a means of biofeedback to patients with dysphagia in the acute stroke&#xD;
      setting. It will investigate trends in efficacy by comparing biofeedback therapy to usual&#xD;
      care. The results will inform future dosing and efficacy studies.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 26, 2018</start_date>
  <completion_date type="Actual">May 31, 2020</completion_date>
  <primary_completion_date type="Actual">March 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised Controlled Trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants recruited</measure>
    <time_frame>2 weeks</time_frame>
    <description>Count of number of participants can be recruited</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants completing the treatment</measure>
    <time_frame>2 weeks</time_frame>
    <description>Count of number of participants completing the treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Average number of sessions completed</measure>
    <time_frame>2 weeks</time_frame>
    <description>Average number of sessions completed across participants.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Swallow function - severity</measure>
    <time_frame>Pre and post 3 week intervention intervention and at 90 days</time_frame>
    <description>Using Dysphagia Severity Rating Scale - scale of 0-16. 0 is normal, 16 is the most severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Swallow function - intake</measure>
    <time_frame>Pre and post 3 week intervention intervention and at 90 days</time_frame>
    <description>Functional Oral Intake Scale - 7 point scale from 1-7. Higher number indicated increased amount and normality of oral intake.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Swallow physiology - PAS</measure>
    <time_frame>Pre and post 2 week intervention</time_frame>
    <description>Videofluoroscopy assessment to measure swallow safety with regards to penetration/aspiration using the Penetration Aspiration Scale (PAS). 8 point scale. The higher the number the increase in penetration/aspiration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in swallow physiology - timing</measure>
    <time_frame>Pre and post 2 week intervention</time_frame>
    <description>Videofluoroscopy assessment to measure timing of swallow physiology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Pre and post 2 week intervention and at 90 days</time_frame>
    <description>Dysphagia Handicap Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Clinical outcomes - disability</measure>
    <time_frame>Pre and post 2 week intervention and at 90 days.</time_frame>
    <description>Disability - using the Modified Rankin scale. Scale from 0-6 with higher numbers signifying increased disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Clinical outcomes - stroke severity</measure>
    <time_frame>Pre and post 2 week intervention</time_frame>
    <description>Stroke severity - NIHSS. Scale from 0-42. Increased number means increase in stroke severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Clinical outcomes - tube status</measure>
    <time_frame>Pre and post 2 week intervention and at 90 days.</time_frame>
    <description>Feeding tube status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Clinical outcomes - mortality</measure>
    <time_frame>Pre and post 2 week intervention and at 90 days.</time_frame>
    <description>Mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Clinical outcomes - pneumonia</measure>
    <time_frame>Pre and post 2 week intervention and at 90 days.</time_frame>
    <description>Presence of pneumonia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Stroke, Acute</condition>
  <condition>Dysphagia, Oropharyngeal</condition>
  <arm_group>
    <arm_group_label>Biofeedback group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dysphagia therapy using surface EMG as biofeedback - 10 x 45 minute sessions of swallow strength and skill training using surface electromyography as biofeedback tool. This group will also receive usual care provided by Speech and Language Therapists, which may involve assessment, review, therapy, patient/family education.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group will receive usual care provided by Speech and Language Therapists, which may involve assessment, review, therapy, patient/family education</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dysphagia therapy using surface EMG as biofeedback</intervention_name>
    <description>10 x 45 minute sessions over 14 days</description>
    <arm_group_label>Biofeedback group</arm_group_label>
    <other_name>Biofeedback</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Usual care may include the following Speech and Language Therapy interventions; assessment, review, therapy, patient/family education etc.. Dose will vary.</description>
    <arm_group_label>Biofeedback group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  New diagnosis stroke, new dysphagia, medically stable, adequate trunk strength for&#xD;
             videofluoroscopy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe cognitive impairment, previous dysphagia, previous neurological condition,&#xD;
             severe visual impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy England, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nottingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Derby Hospital</name>
      <address>
        <city>Derby</city>
        <state>Derbyshire</state>
        <zip>DE22 3NE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>November 29, 2017</study_first_submitted>
  <study_first_submitted_qc>April 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2018</study_first_posted>
  <last_update_submitted>October 28, 2020</last_update_submitted>
  <last_update_submitted_qc>October 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deglutition Disorders</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

